Trench Rossi Watanabe has a notable life sciences practice, which shines in corporate transactions, technology transfer agreements, IP-related issues, and regulatory matters. The team is regularly sought out by major international clients from the pharmaceutical, healthcare, and cosmetics sectors. Team lead and public law expert Henrique Frizzo is especially active in the healthcare sector, advising on healthcare regulations and proceedings before regulatory authorities, most notably ANVISA. Co-head Marcela Trigo frequently represents companies in patent litigation, and advises on trade secrets, and compulsory licensing. An integral part of the team, Felipe Zaltman is noted for his patent litigation expertise related to pharmaceuticals.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Trench Rossi Watanabe's team is the best qualified for matters related to the pharmaceutical industry, especially in highly complex topics such as technology transfers, PDPs, risk sharing contracts, etc. Of all the large Brazilian firms, there is no team with as much knowledge and experience in these topics. The team manages to provide its guidance in a business-oriented and always impeccable manner.'
‘The support we have from Henrique Frizzo is essential. He has a lot of technical knowledge, knowledge of the industry and our company, which allows him to respond quickly, accurately and adapt the language to our business needs. When I need any support from the team, in general, I contact Henrique as he ensures that these standards are respected by the other teams that serve us.’
‘Trench Rossi Watanabe's practice has a unique quality in the services provided across all areas of law. In addition to excellent technical knowledge, the firm operates on a horizontal front in the pharmaceutical market, knowing all the main interrelated topics of the industry.’
‘Henrique Frizzo is one of the greatest specialists in the life sciences sector in Brazil. Henrique is a lawyer focused on effectively understanding the industry's problems and seeking concrete, feasible solutions that protect companies from possible unwanted risks. Carla Bacchin Fernandes de Moraes Cox has robust technical-regulatory knowledge of the pharmaceutical market, and is capable of meeting all complex demands autonomously, quickly and assertively.'
‘Technical knowledge, quality service, personal attention and team availability.’
Kernmandanten
- Abbott
- Alexion
- Allergan
- Alnylam
- Amicus Therapeutics
- Astellas
- Astrazeneca
- Baxter Hospitalar
- Biogen
- Biotronik
Highlight-Mandate
- Assisting AstraZeneca with a major project involving patents related to dapagliflozin.
- Assisting AstraZeneca with monitoring possible copy industries that aimed at launching infringing products during AstraZeneca's patent terms.
- Advised Novartis AG on pursuing a patent term compensation case, based on a new reading of the Brazilian laws.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Henrique Frizzo; Marcela Trigo
Weitere Kernanwält*innen
Felipe Zaltman; Carla Bacchin Fernandes de Moraes Cox